HIF1A and endometrial cancer: In conclusion, multimodal parameters by ESWAN and DCE-MRI were promise to serve as an important guide for quantitatively evaluating HIF-1α expression in endometrial cancer, which may help to predict the prognosis of the tumor and appropriately adjust the therapeutic regimen.